Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 13 recruiting now later-stage tilt

Pregnancy, High Risk: later-stage trial registry

13 of 21 indexed Pregnancy, High Risk trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #797 of 28,707 conditions by registered trial count.

21 US clinical trials · 13 currently recruiting · #797 of 28,707 conditions by registered trial count

Pregnancy, High Risk: 21 US clinical trials tracked, 13 recruiting.

Pregnancy, High Risk is the subject of 21 registered US clinical trials on ClinicalTrials.gov, 13 of them currently open to new participants. 6 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Ohio State University, running 5 of these trials.

Enrollment posture brief

Registry condition pregnancy-high-risk

OPEN 13 | RECR 62% | LATE 6 | EARLY 2 | RANK #797 | SPON 5

Nearest open-share peer: Rotator Cuff Tears (62% recruiting · 21 trials)

Pregnancy, High Risk (this)62%Anal Cancer42.9%Allergic Conjunctivitis14.3%Attention Deficit Disorder W4.8%Adult Acute Myeloid Leukemia0%
Open-enrollment share among volume-matched conditions near Pregnancy, High Risk

Pregnancy, High Risk lists 13 open slots (62% of 21 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Pregnancy, High Risk on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Pregnancy, High Risk is recruiting above its size-band peers.

    13 of 21 indexed trials (61.9%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Pregnancy, High Risk research.

    Ohio State University accounts for 5 of 21 trials (23.8%). 15 distinct sponsors appear on at least one study for this condition label.

  3. Typical Pregnancy, High Risk enrolment sits around 104 participants.

    Median target enrolment is 104 among the 21 trials that report a genuine target (sentinel values excluded). 10 of those (47.6%) plan for fewer than 100 participants.

  4. Pregnancy, High Risk research is mostly interventional.

    15 interventional and 6 observational studies make up this index (71.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 22Phase 31Phase 45

Open and recent trials

21 total, page 1 of 1

RECRUITING Phase 4 1,572 participants

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

Ohio State University

NCT06445946

RECRUITING 1,000 participants

Commercial or Open Source Closed Loop Impact on Pregnancy Study

University of California, San Francisco

NCT06654713

RECRUITING NA 828 participants

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

Indiana University

NCT05124808

RECRUITING 728 participants

Relugolix Pregnancy Registry: An Observational Study of the Safety of Relugolix-Containing Therapy Exposure in Pregnant Women and Their Offspring

Sumitomo Pharma Switzerland

NCT05739123

RECRUITING 500 participants

T1D Pregnancy & Me

Jaeb Center for Health Research

NCT06959316

RECRUITING NA 180 participants

Continuous Glucose Monitor Use in Pregnancy

University of Massachusetts, Worcester

NCT05317585

RECRUITING Phase 2 150 participants

Resources, Inspiration, Support and Empowerment (RISE) for Black Pregnant Women

Cedars-Sinai Medical Center

NCT05552053

RECRUITING NA 124 participants

Successfully Achieving and Maintaining Euglycemia During Pregnancy for Type 2 Diabetes Through Technology and Coaching

Ohio State University

NCT05662462

RECRUITING NA 104 participants

A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP) and Follow Up PP CARE

Ohio State University

NCT05909046

RECRUITING NA 80 participants

Early Detection of Gestational Diabetes Mellitus in Pregnancy

University of Massachusetts, Worcester

NCT05388643

RECRUITING Phase 4 56 participants

Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)

Ohio State University

NCT06396078

RECRUITING Phase 3 40 participants

Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy (Patch BRIDGE)

Washington University School of Medicine

NCT05790252

RECRUITING Phase 4 12 participants

Anticoagulation Profile in Pregnant Women Treated With Three Times a Day of Low Molecular Weight Heparin (LMWH)

University of California, Irvine

NCT04861103

ACTIVE NOT RECRUITING 530 participants

MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination Therapy

Sumitomo Pharma Switzerland

NCT05739136

ACTIVE NOT RECRUITING Phase 2 120 participants

Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes

University of Alabama at Birmingham

NCT04542148

COMPLETED 74 participants

Safer Conception Intervention for HIV-1 Serodiscordant Couples

University of Washington

NCT03030768

COMPLETED Phase 4 70 participants

Intravenous Insulin vs Subcutaneous Insulin Infusion in Intrapartum Management of Type 1 Diabetes Mellitus

Gianna Wilkie

NCT04599075

COMPLETED NA 56 participants

Daily Meditation Program in Women Admitted to the Antepartum Unit

The University of Texas Health Science Center, Houston

NCT03737279

COMPLETED Phase 4 56 participants

Patient Versus Provider-led Titration of Insulin for Glycemic Control in Gestational Diabetes (EMPOWER)

Ohio State University

NCT05922033

COMPLETED 46 participants

MOM NEST Study: Maternal Opioid Medication: Naltrexone Efficacy Study

Boston Medical Center

NCT03718104

COMPLETED NA 20 participants

A Randomized Placebo Controlled Pilot Study of Probiotic Supplementation in At-risk Pregnant Women

University of Illinois at Chicago

NCT03646487

Phase Distribution

PhaseTrial count
Phase 2 2
Phase 3 1
Phase 4 5

Named interventions

Most-linked intervention names on Pregnancy, High Risk records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Insulin Drug
2 trials
Breast milk analysis Other
1 trials
Genetic and epigenetic analysis Genetic
1 trials
Safety and Efficacy Other
1 trials
Pharmacokinetic analysis Other
1 trials
Provider-led Insulin (standard care) Drug
1 trials
Patient-led Insulin (intervention group) Drug
1 trials
Placebo in capsule form Other
1 trials

US sites by state

Facility locations filed on Pregnancy, High Risk trials. A trial with sites in several states counts in each.

Massachusetts 7 trials
Ohio 6 trials
Texas 4 trials
California 4 trials
Alabama 4 trials
Pennsylvania 3 trials
North Carolina 3 trials
South Carolina 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Pregnancy, High Risk page

21 registered trials, 13 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pregnancy, High Risk condition card totals 21 registered trials; most-linked intervention Insulin; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.